Commentary on local therapy in men who present with a metastatic prostate cancer from special issue senior guest editor

American Journal of Clinical and Experimental Urology

Isaac Yi Kim¹ 

[1]Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA

DOI  :  

学科分类：医学（综合）

来源: e-Century Publishing Corporation

【 摘 要 】

In contrast to localized disease, there is no effective cure for men who present with metastatic prostate cancer (mPCa) as the 5-year relative survival rate is only 28% [1]. More importantly, it has been reported that the outcome in men who present with mPCa has not improved over the last two decades [2]. Given such dismal prognosis of mPCa, new ideas and novel approaches must be explored. In this regard, recently emerging data suggest that local tumor control may enhance survival in men with mPCa [3-7]. In this special issue, we have attempted to review the latest science as well as the evidence for local therapy in men who present with a mPCa.

【 授权许可】

CC BY-NC